Annual report pursuant to Section 13 and 15(d)

Segment Reporting

v3.19.2
Segment Reporting
12 Months Ended
Jun. 30, 2019
Segment Reporting  
Segment Reporting

18.    Segment Reporting

In accordance with FASB ASC 280, “Segment Reporting,” the Company discloses financial and descriptive information about its reportable segments. The Company operates in two segments, iBio, Inc. and iBio CDMO. These segments are components of the Company about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The accounting policies of the segments are the same as those described in the Summary of Significant Accounting Policies.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended June 30, 2019 (in thousands)

    

iBio, Inc.

 

iBio CDMO

 

Eliminations

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues - external customers

 

$

2,018

 

$

 —

 

$

 —

 

$

2,018

Revenues - intersegment

 

 

1,465

 

 

1,995

 

 

(3,460)

 

 

 —

Research and development

 

 

4,344

 

 

3,164

 

 

(2,034)

 

 

5,474

General and administrative

 

 

4,297

 

 

9,461

 

 

(1,426)

 

 

12,332

Operating loss

 

 

(5,158)

 

 

(10,630)

 

 

 —

 

 

(15,788)

Interest expense

 

 

 —

 

 

(1,900)

 

 

 —

 

 

(1,900)

Interest and other income

 

 

79

 

 

12

 

 

 —

 

 

91

Consolidated net loss

 

 

(5,079)

 

 

(12,518)

 

 

 —

 

 

(17,597)

Total assets

 

 

37,442

 

 

6,399

 

 

(13,255)

 

 

30,586

Fixed assets, net

 

 

 2

 

 

24,378

 

 

 —

 

 

24,380

Intangible assets, net

 

 

1,374

 

 

 —

 

 

 —

 

 

1,374

Depreciation expense

 

 

 2

 

 

1,425

 

 

 —

 

 

1,427

Amortization of intangible assets

 

 

322

 

 

 —

 

 

 —

 

 

322

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended June 30, 2018 (in thousands)

    

iBio, Inc.

    

iBio CDMO

    

Eliminations

    

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues - external customers

 

$

407

 

$

37

 

$

 —

 

$

444

Revenues - intersegment

 

 

1,329

 

 

461

 

 

(1,790)

 

 

 —

Research and development

 

 

2,470

 

 

1,943

 

 

(427)

 

 

3,986

General and administrative

 

 

4,547

 

 

7,460

 

 

(1,322)

 

 

10,685

Operating loss

 

 

(5,281)

 

 

(8,946)

 

 

 —

 

 

(14,227)

Interest expense

 

 

 —

 

 

(1,915)

 

 

 —

 

 

(1,915)

Interest and other income

 

 

28

 

 

 6

 

 

 —

 

 

34

Consolidated net loss

 

 

(5,253)

 

 

(10,855)

 

 

 —

 

 

(16,108)

Total assets

 

 

36,986

 

 

18,879

 

 

(12,782)

 

 

43,083

Fixed assets, net

 

 

 5

 

 

25,147

 

 

 —

 

 

25,152

Intangible assets, net

 

 

1,620

 

 

 —

 

 

 —

 

 

1,620

Depreciation expense

 

 

 3

 

 

1,365

 

 

 —

 

 

1,368

Amortization of intangible assets

 

 

341

 

 

 —

 

 

 —

 

 

341